This is a recall for Emerade 500 microgram pens only. This is a different alert to that issued on 04 March 2020 for Emerade 150 microgram auto-injectors and on 07 April 2020…
Read more
The Anaphylaxis Campaign, a UK charity that supports the growing number of adults and children affected by severe allergies, has today (6 May 2020) announced its new president, former vice-president David Reading…
Read more
In the run-up to our annual Anaphylaxis Awareness Week (4 – 10 May), the Anaphylaxis Campaign would like to welcome our new youth ambassador Dan Kelly, founder of the ‘May Contain’ blog (Instagram @_maycontain) and podcast, who will…
Read more
The Anaphylaxis Campaign recently became aware of news reports in the media stating that major supermarkets had introduced new social distancing rules in store, asking customers not to touch food items unless…
Read more
Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, had previously experienced manufacturing challenges which resulted in interruptions in the supply of EpiPen Jr 0.15mg and EpiPen 0.3mg…
Read more
The Anaphylaxis Campaign is aware of a number of companies offering intravenous vitamins which they claim can boost nutritional wellbeing. As a charity that supports the allergic community, we have concerns about the…
Read more
Our 2019 impact report is now available to view online. Every year we look back at the differences we have made to the allergic community and announce our vision for the future….
Read more
7th April 2020 This is a different alert to that issued on 04 March 2020 for Emerade 150 microgram auto-injectors. The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA])…
Read more
On the 23rd March 2020 the government announced that all restaurants, pubs and cafés would have to close as part of measures to combat the spread of the novel coronavirus. The government…
Read more